CITIUS PHARMACEUTICALS

citius-pharmaceuticals-logo

Citius Pharmaceuticals is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for large and growing markets. Citius products offer new and expanded indications for previously approved pharmaceutical products as a means to achieve leading market position or market exclusivity. By using previously approved drugs with substantial safety and efficacy data, Citius seeks to reduce the risks associated with pharmaceutical product development. Citius is currently advancing two proprietary product candidates, our Mino-Lokโ„ข product and a Hydrocortisone-Lidocaine formulation. Citius believes the markets for its products are large and underserved by the current standard of care.

#SimilarOrganizations #People #Financial #Event #Website #More

CITIUS PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Life Science Medical Therapeutics

Founded:
2007-01-01

Address:
Cranford, New Jersey, United States

Country:
United States

Website Url:
http://www.citiuspharma.com

Total Employee:
11+

Status:
Active

Contact:
(908)967-6677

Email Addresses:
[email protected]

Total Funding:
144.9 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Domain Not Resolving


Similar Organizations

aclaris-therapeutics-logo

Aclaris Therapeutics

Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.

alnylam-pharmaceuticals-logo

Alnylam Pharmaceuticals

Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.

forma-therapeutics-logo

FORMA Therapeutics

FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.

immatics-biotechnologies-logo

immatics biotechnologies

immatics is a biopharmaceutical company focused on the development of immunotherapeutic substances for cancer therapy.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.


Current Advisors List

myron-holubiak_image

Myron Holubiak Member of the Board of Directors @ Citius Pharmaceuticals
Board_member

william-kane_image

William Kane Member of the Board of Directors @ Citius Pharmaceuticals
Board_member

issam-raad_image

Issam Raad Member of the Scientific Advisory Board @ Citius Pharmaceuticals
Advisor

suren-dutia_image

Suren Dutia Member of the Board of Directors @ Citius Pharmaceuticals
Board_member

carol-webb_image

Carol Webb Member of the Board of Directors @ Citius Pharmaceuticals
Board_member

mark-rupp_image

Mark Rupp Member of the Scientific Advisory Board @ Citius Pharmaceuticals
Advisor

howard-safir_image

Howard Safir Lead Independent Director @ Citius Pharmaceuticals
Board_member
2014-04-01

eugene-holuka_image

Eugene Holuka Member of the Scientific Advisory Board @ Citius Pharmaceuticals
Advisor

Current Employees Featured

jaime-bartushak_image

Jaime Bartushak
Jaime Bartushak CFO @ Citius Pharmaceuticals
CFO
2016-01-01

gary-talarico_image

Gary Talarico
Gary Talarico Executive Vice President of Operations @ Citius Pharmaceuticals
Executive Vice President of Operations
2016-03-01

myron-holubiak_image

Myron Holubiak
Myron Holubiak Chief Executive Officer @ Citius Pharmaceuticals
Chief Executive Officer
2016-04-01

leonard-mazur_image

Leonard Mazur
Leonard Mazur CEO & Chairman of the Board of Directors @ Citius Pharmaceuticals
CEO & Chairman of the Board of Directors
2007-01-01

john-westman_image

John Westman
John Westman Vice President Project Management @ Citius Pharmaceuticals
Vice President Project Management
2021-06-01

not_available_image

Kelly Creighton
Kelly Creighton EVP of Chemistry, Manufacturing & Controls (CMC) @ Citius Pharmaceuticals
EVP of Chemistry, Manufacturing & Controls (CMC)
2021-11-01

alan-lader_image

Alan Lader
Alan Lader Vice President of Clinical Operations @ Citius Pharmaceuticals
Vice President of Clinical Operations
2016-03-01

andrew-scott_image

Andrew Scott
Andrew Scott Vice President of Corporate Development @ Citius Pharmaceuticals
Vice President of Corporate Development
2016-06-01

Founder


leonard-mazur_image

Leonard Mazur

Stock Details


Company's stock symbol is NASDAQ:CTXR

Acquisitions List

Date Company Article Price
2016-04-04 Leonard-Meron Biosciences Leonard-Meron Biosciences acquired by Citius Pharmaceuticals N/A

Investors List

leonard-mazur_image

Leonard Mazur

Leonard Mazur investment in Post-IPO Equity - Citius Pharmaceuticals

myron-holubiak_image

Myron Holubiak

Myron Holubiak investment in Post-IPO Equity - Citius Pharmaceuticals

Official Site Inspections

http://www.citiuspharma.com Semrush global rank: 2.51 M Semrush visits lastest month: 7.02 K

Unable to get host informations!!!

Loading ...

More informations about "Citius Pharmaceuticals"

Citius Pharmaceuticals, Inc. - About

Contact Us Citius Pharmaceuticals, Inc. 11 Commerce Drive, First Floor Cranford, NJ 07016 908-967-6677 [email protected]See details»

Citius Pharmaceuticals - Crunchbase Company Profile & Funding

Citius Pharmaceuticals is a biopharmaceutical company that develops and commercializes therapeutic products.See details»

Citius Pharmaceuticals, Inc. | LinkedIn

Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a โ€ฆSee details»

Citius Pharmaceuticals Announces Nomination of Pharmaceutical โ€ฆ

Jan 23, 2024 Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first โ€ฆSee details»

Citius Pharmaceuticals - VentureRadar

"Citius is a late-stage specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives and cancer care.See details»

Citius Pharmaceuticals Announces Key Management Realignment โ€ฆ

Apr 13, 2022 With a planned BLA submission for I/ONTAK later this year, along with the expected completion of enrollment in the Mino-Lok® trial in 2022, now is the ideal time to โ€ฆSee details»

Citius Pharmaceuticals, Inc. - About - Overview

Unlocking Potential. Faster. Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in โ€ฆSee details»

Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2024 ...

Aug 12, 2024 Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization โ€ฆSee details»

Citius Pharma - Overview, News & Similar companies

View Citius Pharma (www.citiuspharma.com) location in New Jersey, United States , revenue, industry and description. Find related and similar companies as well as employees by title and โ€ฆSee details»

Citius Pharmaceuticals Details Near-Term Milestones for Late โ€ฆ

Jul 10, 2024 Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first โ€ฆSee details»

Citius Pharmaceuticals Announces Closing of $15 Million โ€ฆ

Apr 30, 2024 In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. For more information, please visit โ€ฆSee details»

About - Board of Directors - Person Details - Citius Pharma

Kelly joined Citius from Clinipace Worldwide, a leading global contract research organization, where he served as Vice President of Regulatory and Strategic Development. As a senior โ€ฆSee details»

Citius Pharmaceuticals Executes Definitive Agreement to Merge โ€ฆ

Oct 24, 2023 Citius Pharmaceuticals, Inc. to receive $675 million in equity of Citius Oncology, Inc. and retain approximately 90% majority control in publicly listed Citius Oncology, Inc. post โ€ฆSee details»

Citiusโ€™ first FDA decision date is approaching - PharmaVoice

Jul 26, 2024 Citius Pharmaceuticals CEO Leonard Mazur has personally invested $22.5 million into the company, which is fast approaching a potential turning point.See details»

Citius Pharmaceuticals, Inc. - About - Board of Directors

Dec 31, 2023 Mr. Mazur is an accomplished entrepreneur and pharmaceutical industry executive with notable accomplishments in founding, building and creating value and returns โ€ฆSee details»

Citius Pharma - PitchBook

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four โ€ฆSee details»

Citius Pharmaceuticals Achieves Primary and Secondary Endpoints โ€ฆ

Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in โ€ฆSee details»

Citius Pharmaceuticals, Inc. - Investors - Investment Highlights

Why Invest? FDA approved biologic for the treatment of cutaneous T-cell lymphoma Diversified pipeline of potential first-in-class products with multiple near-term staged catalysts Attractive โ€ฆSee details»

Citius Pharmaceuticals, Inc. - Investors - Financials & SEC Filings ...

By providing your email address below, you are providing consent to Citius Pharmaceuticals, Inc. to send you the requested Investor Email Alert updates.See details»

linkstock.net © 2022. All rights reserved